. . . . . . . . "Clozapine is indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state" . . . "NeuroDKG" . . . "patients (...) who are judged to be at chronic risk for re-experiencing suicidal behavior" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "DFkf5aQnQ6VDdqsWS7w0BZ4Qzft8Nla1/T3xrbhLTqiIWSKvURWNKYKpx+9aDCKrJUEBlknVjHCKH7tFtctE6C+NxNeEyHBucRDE8usCQPyfKe81nLaVkNIz/Rq86s/0GzmONt3Wq4Pm4/Wb/488uemkr3Pr+FnwNbMF3DazVS0=" . . "2021-03-23T20:26:20.681+01:00"^^ . . . . .